CUAMC
China Universal Asset Management Company’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
25,243
+67
| +0.3% | +$1.16K | 0.04% | 250 |
|
|
2025
Q1 | $551K | Sell |
25,176
-1,200
| -5% | -$26.2K | 0.05% | 241 |
|
|
2024
Q4 | $842K | Buy |
26,376
+2,956
| +13% | +$94.3K | 0.08% | 184 |
|
|
2024
Q3 | $675K | Buy |
23,420
+9,160
| +64% | +$264K | 0.07% | 184 |
|
|
2024
Q2 | $547K | Sell |
14,260
-8,922
| -38% | -$342K | 0.08% | 138 |
|
|
2024
Q1 | $1.36M | Buy |
23,182
+9,472
| +69% | +$557K | 0.17% | 106 |
|
|
2023
Q4 | $821K | Buy |
13,710
+10,682
| +353% | +$639K | 0.16% | 122 |
|
|
2023
Q3 | $115K | Buy |
3,028
+687
| +29% | +$26.1K | 0.03% | 190 |
|
|
2023
Q2 | $213K | Sell |
2,341
-25
| -1% | -$2.28K | 0.07% | 128 |
|
|
2023
Q1 | $156K | Buy |
2,366
+1,243
| +111% | +$82K | 0.05% | 121 |
|
|
2022
Q4 | $58.1K | Buy |
1,123
+94
| +9% | +$4.86K | 0.02% | 134 |
|
|
2022
Q3 | $70K | Buy |
+1,029
| New | +$70K | 0.03% | 118 |
|